Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Recent data are limited on the effects of statins or other adjunctive treatments in patients without a history of a cardiovascular event.
“Recent data are limited on the effects of statins or other adjunctive treatments in patients without a history of a cardiovascular event, leading some authors to question whether the benefits of cholesterol lowering exceed the harms in these patients.[4][5][6][7]”
From Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients (2023) · cites this paper as [4]
The effects of bempedoic acid on cardiovascular outcomes in statin-intolerant patients without a prior cardiovascular event (primary prevention) have not been fully described.
“The effects of bempedoic acid on cardiovascular outcomes in statin-intolerant patients without a prior cardiovascular event (primary prevention) have not been fully described.”
From Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients (2023) · cites this paper as [4]
Primary prevention patients are currently undertreated with lipid-modulating therapies.
“Primary prevention patients are currently undertreated with lipid-modulating therapies.[4][5][6][7]”
From Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients (2023) · cites this paper as [4]
Cites
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449 · see citing works
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453 · see citing works
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697 · see citing works
Preiss, D. (2011) · JAMA · doi:10.1001/jama.2011.860 · Cited by 1,390 · see citing works
Furberg, C. D., Adams, H. P., Applegate, W. B., Byington, R. P., Espeland, M. A., Hartwell, T., Hunninghake, D. B., Lefkowitz, D. S., Probstfield, J. L., & Riley, W. A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1679 · Cited by 865 · see citing works
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
US Preventive Services Task Force, Bibbins-Domingo, K. B., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F., Gillman, M. W., Kemper, A. R., Krist, A. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.15450 · Cited by 590 · see citing works
Statins for Prevention of Cardiovascular Disease in Adults
Chou, R., Dana, T., Blazina, I., Daeges, M., & Jeanne, T. L. (2016) · JAMA · doi:10.1001/jama.2015.15629 · Cited by 570 · see citing works
Ray, K. K. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.182 · Cited by 446 · see citing works
Statin myopathy: A common dilemma not reflected in clinical trials
Fernandez, G., Spatz, E. S., Jablecki, C. K., & Phillips, P. S. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10073 · Cited by 216 · see citing works
Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults
Sugiyama, T., Tsugawa, Y., Tseng, C., Kobayashi, Y., & Shapiro, M. F. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1927 · Cited by 144 · see citing works
Prepared by the Cholesterol Treatment Trialists' (CTT) Collaboration (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80744-9 · Cited by 101 · see citing works
Statin Use in Very Elderly Individuals, 1999-2012
Johansen, M. E., & Green, L. A. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4302 · Cited by 34 · see citing works
Elimination of Lipid Levels From Quality Measures
Stine, N. W., & Chokshi, D. A. (2014) · JAMA · doi:10.1001/jama.2014.15600 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study
Williams, M. C., Moss, A. J., Dweck, M. R., Adamson, P. D., Alam, S. R., Hunter, A. L., Shah, A. S. V., Pawade, T., Weir-McCall, J. R., Roditi, G., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.066 · Cited by 622 · see citing works
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults
Han, B. H., Sutin, D. G., Williamson, J. D., Davis, B. R., Piller, L. B., Pervin, H., Pressel, S., & Blaum, C. S. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1442 · Cited by 178 · see citing works
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Nissen, S. E., Menon, V., Nicholls, S. J., Brennan, D., Laffin, L., Ridker, P., Ray, K. K., Mason, D., Kastelein, J. J. P., Cho, L., et al. (2023) · JAMA · doi:10.1001/jama.2023.9696 · Cited by 146 · see citing works
Wieringa, S., Engebretsen, E., Heggen, K. M., & Greenhalgh, T. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.8325 · Cited by 38 · see citing works
Quaternary prevention: a balanced approach to demedicalisation
Norman, A. H., & Tesser, C. D. (2018) · British Journal of General Practice · doi:10.3399/bjgp19x700517 · Cited by 30 · see citing works
Predictors of statin use among older adults: A nationwide cross-sectional study
Ofori‐Asenso, R., Ilomäki, J., TACEY, M. A., Zomer, E., Curtis, A. J., Bell, J. S., Zoungas, S., & Liew, D. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.10.002 · Cited by 17 · see citing works
Bugiardini, R., Yoon, J., Mendieta, G., Kedev, S. A., Zdravkovic, M. D., Vasiljević, Z., Miličić, D., Manfrini, O., van der Schaar, M., Gale, C. P., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.354 · Cited by 18 · see citing works
Lessons from the controversy over statins
Godlee, F. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30721-3 · Cited by 14 · see citing works
Bots, S. H., Onland‐Moret, N. C., Jancev, M., Hollander, M., Tulevski, I. I., Hofstra, L., Somsen, G. A., & den Ruijter, H. M. (2022) · Open Heart · doi:10.1136/openhrt-2021-001900 · Cited by 13 · see citing works
Protic, O., Pillo, R. D., Montesanto, A., Galeazzi, R., Matacchione, G., Giuliani, A., Sabbatinelli, J., Gurău, F., Silvestrini, A., Olivieri, F., et al. (2022) · Nutrients · doi:10.3390/nu14142812 · Cited by 11 · see citing works
The Myth of the Placebo Response
Jonas, W. B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00577 · Cited by 10 · see citing works
Statins for Primary Cardiovascular Disease Prevention
Habib, A. R., Katz, M. H., & Redberg, R. F. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.3204 · Cited by 9 · see citing works
Self-citationDiamond, D. M., de Lorgeril, M., Kendrick, M. E., Ravnskov, U., & ROSCH, P. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0205138 · Cited by 8 · see citing works
Medikamentöse Therapie kardiologischer Erkrankungen im Alter
Schwinger, R. H. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-108475 · Cited by 2 · see citing works
Bardoczi, J. B., Brunner, L., Spinewine, A., Rodondi, N., & Aubert, C. E. (2024) · Gerontology and Geriatric Medicine · doi:10.1177/23337214241245918 · Cited by 1 · see citing works
Do journals and corporate sponsors back certain views in topics where disagreement prevails?
Ingwersen, P., Holm, S., Larsen, B., & Ploug, T. (2020) · Scientometrics · doi:10.1007/s11192-020-03743-8 · Cited by 1 · see citing works
A review of decision aids to assess cardiovascular risk
Westman, E. C. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000760 · Cited by 1 · see citing works
The Fallacy of OTC Statin Therapy
Demasi, M., & DuBroff, R. J. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.1380 · Cited by 1 · see citing works
Registry Evidence for Modulation of the Acute Ischemic Heart Disease Pathway
Schocken, D. D. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.343 · Cited by 1 · see citing works
Differenzierte medikamentöse Therapie – im höheren Lebensalter besonders wichtig
Erdmann, E. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-105171
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
(2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0124
- Authors
- Redberg, R. F., & Katz, M. H.
- Affiliations
- University of California, San Francisco (US)
- Los Angeles County Department of Health Services (US)
- ORCID
- Redberg, Rita F.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2017-01-01
- Volume
- 177
- Issue
- 1
- Pages
- 21
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2556188414
- Cited by
- 22
- References
- 14
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 6 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 2
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- statins, primary prevention, cardiovascular disease prevention, lipid-lowering therapy, hypercholesterolemia
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Humans, Internal Medicine, Middle Aged, Periodicals as Topic, Primary Prevention, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
